Quality
Maintaining a strong focus on product quality, reliability and responsible pharmaceutical practices.
A vision for affordable and accessible healthcare.
Company profile: who we are, why we exist, and the four principles the business is being built on.
Who we are
Established 2024, India
- Nature of business
- Healthcare-focused pharmaceutical initiative
- International association
- NRI Mr. Yashwant Singh - Overseas office in Mississauga, Greater Toronto, Canada
- Market
- Indian pharmaceutical market
- Therapeutic focus
- Oncology, long-term therapies, supportive care
Malta International Pharma is a healthcare-focused pharmaceutical initiative established in 2024 with a clear and meaningful objective: to contribute towards making quality medicines more affordable and accessible to patients across India.
With international association and exposure, including the involvement of NRI Mr. Yashwant Singh and the establishment of an office in Toronto, Canada, Malta International Pharma is envisioned to build a strong and responsible presence in the Indian pharmaceutical market.
Our approach combines quality, accessibility and patient-centric thinking, with a particular focus on therapeutic areas where the cost of long-term treatment can create a significant financial burden for patients and their families.
Our purpose
Access to essential medicines should extend beyond economic boundaries.
Our endeavour is to support patients, particularly those from economically weaker sections of society, by working towards greater availability of quality medicines at affordable prices.
We are especially committed to areas involving long-term therapies, oncology and other serious medical conditions, where continuous treatment can place considerable pressure on household finances.
Our vision
“Quality healthcare should not be a privilege. It should be accessible to everyone, regardless of their financial circumstances.”
Our commitment
We aim to build Malta International Pharma on four fundamental principles.
Accessibility
Working towards making essential medicines more accessible to patients and healthcare providers.
Affordability
Seeking solutions that reduce the financial burden associated with long-term and critical treatments.
Responsibility
Conducting our business with integrity, transparency and a genuine commitment to the healthcare ecosystem.
Looking ahead
A trusted pharmaceutical organisation with an international outlook.
Malta International Pharma aspires to develop into a trusted pharmaceutical organisation with an international outlook and a strong patient-first approach.
By bringing together international exposure, quality-focused pharmaceutical products and a commitment to affordability, we seek to create sustainable value for patients, healthcare professionals, business partners and the wider Indian healthcare ecosystem.
-
2024
Founded in India
Malta International Pharma is established with a single objective: quality medicines at prices patients can sustain.
-
2024
Overseas office
International association through NRI Mr. Yashwant Singh brings an office at 800 Constellation Drive, Mississauga, in the Greater Toronto Area, and access to global sourcing partners.
-
Today
Oncology-first portfolio
Injectables, oral targeted therapies and supportive care, supplied to hospitals and distributors across India.
-
Ahead
A trusted, patient-first organisation
Expanding the portfolio and partnerships while keeping affordability at the centre of every decision.
Where we are
Rooted in India. Connected to Toronto.
India
Corporate Office - Noida
Operations, distribution & regulatory
C-22, 5th Floor, Tower C, Spectrum MallGH-ECO City, Sector 75Noida, Uttar Pradesh, India
Canada
Overseas Office - Greater Toronto
International association & sourcing
800 Constellation DriveMississauga, Ontario L5R 3L6Canada